Phio Pharmaceuticals

Phio’s proprietary RNA interference (RNAi) technology makes immune cells more effective in killing tumor cells.

Launch date

Jan 2011

Employees

Market cap

Enterprise valuation

($6m) (Public information from Sep 2024)

Marlborough Massachusetts (HQ)

http://phiopharma.com

https://twitter.com/rxipharma https://www.linkedin.com/company/phio-pharmaceuticals-corp/

Authorizing premium user...